Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Thomas

Showing results (41-50 of 262) with videos related to

Pageof 27
Sort By:
Bulletin Du Cancer|October 9, 2002
[Treatment of acute myeloid leukemias in the adult in relapse]Xavier Thomas, Quoc-Hung Le
Expert Opinion on Drug Safety|March 5, 2016
The safety of treatment options for elderly people with acute myeloid leukemiaXavier Thomas, Caroline Le Jeune
European Journal of Haematology|July 2, 2014
Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemiaCaroline Le Jeune, Xavier Thomas
International Journal of Hematologic Oncology|October 11, 2018
Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemiaXavier Thomas, Caroline Le Jeune
Drug Design, Development and Therapy|March 4, 2016
Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemiaCaroline Le Jeune, Xavier Thomas
Expert Opinion on Pharmacotherapy|November 1, 2016
Treating adults with acute lymphocytic leukemia: new pharmacotherapy optionsXavier Thomas, Caroline Le Jeune
Current Treatment Options in Oncology|February 2, 2017
Treatment of Elderly Patients With Acute Myeloid LeukemiaXavier Thomas, Caroline Le Jeune
Hematology (Amsterdam, Netherlands)|August 13, 2003
Prognostic factors in adult acute lymphoblastic leukemiaXavier Thomas, Quoc-Hung Le
Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2017
Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell DiseaseGiovanna Cannas, Solène Poutrel, Xavier Thomas
Expert Opinion on Drug Discovery|May 16, 2017
The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemiaEtienne Paubelle, Florence Zylbersztejn, Xavier Thomas
Pageof 27

Showing results (41-50 of 262) with videos related to

Sort By:
Pageof 27
Bulletin Du Cancer|October 9, 2002
[Treatment of acute myeloid leukemias in the adult in relapse]Xavier Thomas, Quoc-Hung Le
Expert Opinion on Drug Safety|March 5, 2016
The safety of treatment options for elderly people with acute myeloid leukemiaXavier Thomas, Caroline Le Jeune
European Journal of Haematology|July 2, 2014
Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemiaCaroline Le Jeune, Xavier Thomas
International Journal of Hematologic Oncology|October 11, 2018
Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemiaXavier Thomas, Caroline Le Jeune
Drug Design, Development and Therapy|March 4, 2016
Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemiaCaroline Le Jeune, Xavier Thomas
Expert Opinion on Pharmacotherapy|November 1, 2016
Treating adults with acute lymphocytic leukemia: new pharmacotherapy optionsXavier Thomas, Caroline Le Jeune
Current Treatment Options in Oncology|February 2, 2017
Treatment of Elderly Patients With Acute Myeloid LeukemiaXavier Thomas, Caroline Le Jeune
Hematology (Amsterdam, Netherlands)|August 13, 2003
Prognostic factors in adult acute lymphoblastic leukemiaXavier Thomas, Quoc-Hung Le
Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2017
Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell DiseaseGiovanna Cannas, Solène Poutrel, Xavier Thomas
Expert Opinion on Drug Discovery|May 16, 2017
The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemiaEtienne Paubelle, Florence Zylbersztejn, Xavier Thomas
Pageof 27